The Zurich-based startup CellSpring, specialising in 3-Dimensional Cell Culture solutions for high-throughput creation of functional microtissues, announced their collaboration with Plasticell, a biotech company in the United Kingdom. Together they will validate osteogenic cell therapy and 3D cell culture models for high performance drug screening.